Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 27.99 is 11% above its 3-year average of 25.24, around the middle of its 3-year range (0.00–47.43).
As of the fiscal period ended Tuesday, June 30, 2026. 5.57% below its 12-month average of 29.64.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 27.99.
CURRENT RATIO
27.99
CURRENT RATIO AVG TTM
29.64
CURRENT RATIO AVG 3Y
25.24
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-5.57%
CURRENT VS 3Y AVG
+10.92%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+644.52%
vs the sector median at left
Market Cap
$248.50M
Current Ratio
4.70
TTM Avg
7.13
3Y Avg
7.51
5Y Avg
5.68
Market Cap
$247.62M
Current Ratio
0.10
TTM Avg
1.46
3Y Avg
1.56
5Y Avg
2.73
Market Cap
$247.27M
Current Ratio
10.37
TTM Avg
5.14
3Y Avg
8.08
5Y Avg
7.69
Market Cap
$255.88M
Current Ratio
4.48
TTM Avg
4.80
3Y Avg
5.23
5Y Avg
5.23
Market Cap
$241.94M
Current Ratio
3.87
TTM Avg
3.17
3Y Avg
2.70
5Y Avg
2.15
Market Cap
$241.34M
Current Ratio
9.97
TTM Avg
9.81
3Y Avg
16.34
5Y Avg
20.09
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Upstream Bio, Inc. (UPB) | $249.79M | 27.99 | 29.64 | 25.24 | N/A |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $248.50M | 4.70 | 7.13 | 7.51 | 5.68 |
| Galectin Therapeutics Inc. (GALT)vs › | $247.62M | 0.10 | 1.46 | 1.56 | 2.73 |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $247.27M | 10.37 | 5.14 | 8.08 | 7.69 |
| Anika Therapeutics, Inc. (ANIK)vs › | $255.88M | 4.48 | 4.80 | 5.23 | 5.23 |
| AC Immune S.A. (ACIU)vs › | $256.47M | 0.93 | 1.36 | 5.78 | 8.29 |
| Lifecore Biomedical, Inc. (LFCR)vs › | $241.94M | 3.87 | 3.17 | 2.70 | 2.15 |
| Q32 Bio Inc. (QTTB)vs › | $241.39M | 20.30 | 4.91 | 4.89 | 6.73 |
| Quantum-Si incorporated (QSI)vs › | $241.34M | 9.97 | 9.81 | 16.34 | 20.09 |
| Palisade Bio, Inc. (PALI)vs › | $258.63M | 24.26 | 16.09 | 10.56 | 7.83 |
Current Ratio
27.99
Quick Ratio
27.99
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 27.99 |
| 2026-03-31 | 23.14 |
| 2025-12-31 | 26.15 |
| 2025-09-30 | 32.67 |
| 2025-06-30 | 38.27 |
| 2025-03-31 | 47.43 |
| 2024-12-31 | 44.63 |
| 2024-09-30 | 20.90 |
| 2024-06-30 | 23.72 |
| 2024-03-31 | 0.00 |
| 2023-12-31 | 17.96 |
| 2023-09-30 | 0.00 |
